======= ITGA2B ======= == Gene Information == * **Official Symbol**: ITGA2B * **Official Name**: integrin subunit alpha 2b * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3674|3674]] * **UniProt**: [[https://www.uniprot.org/uniprot/P08514|P08514]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ITGA2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ITGA2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607759|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016]. * **UniProt Summary**: Integrin alpha-IIb/beta-3 is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. It recognizes the sequence R-G-D in a wide array of ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha- IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial cell surface. |Integrin alpha2| |FG-GAP| |fibrinogen binding| |platelet alpha granule membrane| |integrin complex| |extracellular matrix binding| |platelet aggregation| |regulation of megakaryocyte differentiation| |homotypic cell-cell adhesion| |integrin-mediated signaling pathway| |cell-matrix adhesion| |positive regulation of leukocyte migration| |platelet degranulation| |platelet activation| |blood microparticle| |cell-substrate adhesion| |regulation of leukocyte migration| |regulation of myeloid cell differentiation| |blood coagulation| |coagulation| |hemostasis| |extracellular matrix organization| |extracellular structure organization| |external side of plasma membrane| |focal adhesion| |regulation of hemopoiesis| |wound healing| |regulation of body fluid levels| |positive regulation of cell migration| |cell-cell adhesion| |positive regulation of cell motility| |positive regulation of cellular component movement| |positive regulation of locomotion| |response to wounding| |cell surface| |regulated exocytosis| |exocytosis| |regulation of cell migration| |regulation of cell motility| |cell adhesion| |biological adhesion| |regulation of locomotion| |regulation of cellular component movement| |secretion by cell| |export from cell| |identical protein binding| |cell activation| |secretion| |positive regulation of immune system process| |regulation of immune system process| |regulation of cell differentiation| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.76| ^Gene^Correlation^ |[[:human genes:c:cactin|CACTIN]]|0.5| |[[:human genes:a:aqr|AQR]]|0.499| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.46| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.447| |[[:human genes:t:tceb3c|TCEB3C]]|0.436| |[[:human genes:v:vasn|VASN]]|0.431| |[[:human genes:t:tfip11|TFIP11]]|0.427| |[[:human genes:p:psmc6|PSMC6]]|0.426| |[[:human genes:c:chd4|CHD4]]|0.425| |[[:human genes:t:tonsl|TONSL]]|0.424| |[[:human genes:c:ccdc64b|CCDC64B]]|0.424| |[[:human genes:c:cln6|CLN6]]|0.423| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.418| |[[:human genes:d:dtl|DTL]]|0.418| |[[:human genes:f:fam160a1|FAM160A1]]|0.418| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.418| |[[:human genes:d:dock6|DOCK6]]|0.418| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.418| |[[:human genes:p:pwp2|PWP2]]|0.412| |[[:human genes:o:orc1|ORC1]]|0.411| |[[:human genes:s:sap30bp|SAP30BP]]|0.408| |[[:human genes:p:psmb4|PSMB4]]|0.406| |[[:human genes:c:cdca3|CDCA3]]|0.406| |[[:human genes:h:hist1h2be|HIST1H2BE]]|0.405| |[[:human genes:n:nupl1|NUPL1]]|0.405| |[[:human genes:t:tbc1d3|TBC1D3]]|0.403| |[[:human genes:c:c14orf93|C14orf93]]|0.402| |[[:human genes:p:polr1a|POLR1A]]|0.402| |[[:human genes:c:copb1|COPB1]]|0.401| |[[:human genes:p:psmc4|PSMC4]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2669 * **Expression level (log2 read counts)**: 0.37 {{:chemogenomics:nalm6 dist.png?nolink |}}